News

Martin Lehr 6/29/20 Martin Lehr 6/29/20

Onapristone Extended Release: Safety Evaluation from Phase I–II Studies with an Emphasis on Hepatotoxicity

Deepak Lala, Tasir Haque, Hannah Feinman, Jianghong Wu, Yuren Wang, Amy Dwyer, Thu Truong, and Carol Lange

San Antonio Breast Cancer Symposium I Poster P6-20-13 I Dec 4-8, 2018

Martin Lehr 3/12/20 Martin Lehr 3/12/20

Tyligand Bioscience and Context Therapeutics Sign Strategic Development Agreement for Onapristone ER

Martin Lehr 3/4/20 Martin Lehr 3/4/20

Leaning Into Investigator Sponsored Trials

By understanding the challenges associated with Investigator Sponsored Trials (IST), stakeholders can utilize ISTs to deliver high-contrast clinical data on underserved patients.